ARTHEx Biotech is a biotechnology company that focuses on investigating antisense RNA compounds to treat diseases with unmet medical needs. Their innovative approach revolves around the use of microRNAs to develop a robust pipeline of therapeutic solutions. With a patient-centric approach, ARTHEx Biotech aims to address critical unmet medical needs and improve patient outcomes.

Led by a team of experienced professionals, including Executive Chairman & CEO Frédéric Legros, PhD, Chief Scientific Officer & Co-Founder Beatriz Llamusí, PhD, Chief Medical Officer Judith Walker, MD, and Director of Operations Pedro Fernández, PhD, ARTHEx Biotech ensures a comprehensive understanding of the industry. Supported by an esteemed Board of Directors and Scientific Advisory Board, which includes top experts in preclinical development, clinical development, drug discovery, chemistry, and toxicology, ARTHEx Biotech demonstrates a commitment to excellence and scientific rigor. With R&D co-funders and a focus on investigating antimiRs, ARTHEx Biotech actively seeks funding opportunities to accelerate research and development for cutting-edge therapeutic solutions.

Their headquarters are located in Paterna, Valencia, Spain. Contact ARTHEx Biotech at info@arthexbiotech. com for more information or to explore collaboration possibilities